rs892605

Variant names:

• chr3-10666176-G-A
• rs892605
• ENST00000646379.1:c.-460+41739C>T

Your query was ambiguous. Multiple possible variants found:

• chr3-10666176-G-A
• chr3-10666176-G-C

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_Strong BA1

The ENST00000646379.1(ATP2B2):​c.-460+41739C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.771 in 152,052 control chromosomes in the GnomAD database, including 45,635 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.77 (45635 hom., cov: 31)
• Consequence: ATP2B2 ENST00000646379.1 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.115

Genes affected

ATP2B2 (HGNC:815): (ATPase plasma membrane Ca2+ transporting 2) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 2. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

ACMG classification

Verdict is Benign. Variant got -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.9).
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.882 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
ATP2B2	XM_005265179.6	c.-460+25215C>T		intron_variant	Intron 1 of 24		XP_005265236.1
ATP2B2	XM_006713175.5	c.-460+41739C>T		intron_variant	Intron 1 of 24		XP_006713238.1
ATP2B2	XM_017006481.3	c.-556+25215C>T		intron_variant	Intron 1 of 25		XP_016861970.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
ATP2B2	ENST00000646379.1	c.-460+41739C>T		intron_variant	Intron 1 of 21			ENSP00000494381.1

Frequencies

GnomAD3 genomes AF: 0.771 AC: 117136 AN: 151934 Hom.: 45594 Cov.: 31

Gnomad AFR AF: 0.890

Gnomad AMI AF: 0.649

Gnomad AMR AF: 0.781

Gnomad ASJ AF: 0.629

Gnomad EAS AF: 0.738

Gnomad SAS AF: 0.734

Gnomad FIN AF: 0.729

Gnomad MID AF: 0.608

Gnomad NFE AF: 0.718

Gnomad OTH AF: 0.751

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.771 AC: 117231 AN: 152052 Hom.: 45635 Cov.: 31 AF XY: 0.770 AC XY: 57258 AN XY: 74320

Gnomad4 AFR AF: 0.890

Gnomad4 AMR AF: 0.781

Gnomad4 ASJ AF: 0.629

Gnomad4 EAS AF: 0.738

Gnomad4 SAS AF: 0.733

Gnomad4 FIN AF: 0.729

Gnomad4 NFE AF: 0.718

Gnomad4 OTH AF: 0.753

Alfa AF: 0.717 Hom.: 45750

Bravo AF: 0.780

Asia WGS AF: 0.763 AC: 2653 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.90
CADD	Benign	2.7
DANN	Benign	0.48

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs892605; hg19: chr3-10707861;